Profiel
Camie Chan worked as an Assistant Professor at the University of California, Davis from 2006 to 2010.
From 2010 to 2016, she was the Deputy Director-Medicine Core Facility at the University of Hong Kong.
In 2019, she briefly served as the Chief Operating Officer & Director at Novoheart Holdings, Inc. Dr. Chan holds an undergraduate degree from The University of Waterloo and graduate and doctorate degrees from the University of Toronto.
Eerdere bekende functies van Camie Chan
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Hong Kong | Corporate Officer/Principal | 01-03-2016 |
| University of California, Davis | Corporate Officer/Principal | 01-01-2010 |
| NOVOHEART HOLDINGS INC. | Financieel Directeur/CFO | - |
Opleiding van Camie Chan
| The University of Waterloo | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
